← Back to Search

AI-Assisted Diagnosis for Stomach Problems (AI-OD Trial)

N/A

Recruiting

Led By Daniel von Renteln, MD

Research Sponsored by Daniel Von Renteln

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 120 days

Awards & highlights

AI-OD Trial Summary

This trial evaluates a new way to monitor and diagnose stomach problems using CADx and 2 expert endoscopists as the gold standard.

Who is the study for?

This trial is for people aged 45-80 who are having an outpatient colonoscopy at the Centre Hospitalier de l'Université de Montréal. They must understand and agree to the study by signing a consent form. It's not for those with severe health risks (ASA status >3), inflammatory bowel diseases, active colitis, blood clotting disorders, or inherited colorectal cancer syndromes.Check my eligibility

What is being tested?

The study tests if artificial intelligence can help doctors decide how often patients need colonoscopies based on real-time analysis during the procedure. This AI-assisted method will be compared to decisions made by two expert endoscopists following established guidelines.See study design

What are the potential side effects?

Since this trial involves using AI during a standard colonoscopy without additional drugs or invasive procedures, there aren't direct side effects from interventions like in drug trials. However, typical risks of colonoscopy may still apply.

AI-OD Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 120 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~120 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 120 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Agreement between (CADx) assisted optical diagnosis and adjudication by two expert endoscopists in establishing surveillance intervals

Secondary outcome measures

Assessing cost savings through AI-assisted optical diagnosis

Assessing efficiency gains through AI-assisted optical diagnosis

Assessing efficiency gains through same-day surveillance interval communication due to implementation of AI-based optical diagnosis

+3 more

AI-OD Trial Design

1Treatment groups

Experimental Treatment

Group I: AI-assisted classification for diminutive polyps during a colonoscopy procedureExperimental Treatment1 Intervention

AI-assisted classification for diminutive polyps during a colonoscopy procedure using the CAD-eye detection and classification system for patienst who agree to undergo optical diagnosis of diminutive colorectal polyps

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Daniel Von RentelnLead Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor

366 Previous Clinical Trials

129,535 Total Patients Enrolled

1 Trials studying Artificial Intelligence

798 Patients Enrolled for Artificial Intelligence

Daniel von Renteln, MDPrincipal InvestigatorCentre hospitalier de l'Université de Montréal (CHUM)

2 Previous Clinical Trials

729 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical research encompass elderly populations over the age of eighty-five?

"This clinical trial is offering participation to individuals aged 45 or older but less than 80 years old."

Answered by AI

Who is most appropriate to participate in this research project?

"Patients must possess an artificial intelligence and fall within the 45-80 age range in order to be deemed eligible for this trial. Currently, 226 people are being accepted into the study."

Answered by AI

Are participants still being solicited for this experiment?

"The trial, which was initially launched on September 1st 2023 and most recently updated on the 22nd of that same month, is seeking out eligible applicants. This information can be found hosted on clinicaltrials.gov."

Answered by AI

Is there a predetermined cap on the number of participants for this trial?

"Affirmative. The information posted on clinicaltrials.gov indicates that this trial is currently seeking patients for enrollment. It was first publicized on September 1st 2023 and the most recent update occurred 22 days afterward; 226 individuals are needed across a single centre of research."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Real-life Implementation of an AI-based Optical Diagnosis

Daniel Von Renteln 2023. "Real-life Implementation of an AI-based Optical Diagnosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06059378.